indocyanine green has been researched along with Cancer of Pelvis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hamada, M; Kinoshita, H; Kita, M; Kurokawa, H; Matsumi, Y; Sekimoto, M | 1 |
| Koshima, I; Narushima, M; Yamamoto, T | 1 |
| Iida, T; Koshima, I; Narushima, M; Oka, A; Seki, Y; Todokoro, T; Yamamoto, N; Yamamoto, T; Yoshimatsu, H | 1 |
3 other study(ies) available for indocyanine green and Cancer of Pelvis
| Article | Year |
|---|---|
Image Navigation Surgery With the Fluorescent Ureteral Catheter of Recurrent Tumors in the Pelvic Cavity.
Topics: Aged; Cohort Studies; Colonic Neoplasms; Female; Fluorescent Dyes; Humans; Indocyanine Green; Intraoperative Complications; Male; Middle Aged; Pelvic Neoplasms; Rectal Neoplasms; Surgery, Computer-Assisted; Ureter; Urinary Catheters | 2022 |
Lymphatic vessel diameter in female pelvic cancer-related lower extremity lymphedematous limbs.
Topics: Adult; Aged; Aged, 80 and over; Anastomosis, Surgical; Female; Follow-Up Studies; Humans; Indocyanine Green; Lower Extremity; Lymphatic Vessels; Lymphedema; Lymphography; Male; Microsurgery; Middle Aged; Pelvic Neoplasms; Prognosis; Retrospective Studies | 2018 |
Indocyanine green velocity: lymph transportation capacity deterioration with progression of lymphedema.
Topics: Disease Progression; Fluorescent Dyes; Humans; Indocyanine Green; Injections, Subcutaneous; Leg; Lymph Nodes; Lymphatic Vessels; Lymphedema; Lymphography; Pelvic Neoplasms; Risk Assessment | 2013 |